カテゴリー： Market Monitor Global, 世界, 医療/バイオ

抗感染症薬の世界市場見通し2023年-2029年

◆英語タイトル：Anti-Infective Medications Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5682）

◆商品コード：MMG23JU5682
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：72
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Anti-Infective Medications Market 調査レポートは次の情報を含め、グローバルにおけるの抗感染症薬市場規模と予測を収録しています。・世界の抗感染症薬市場：売上、2018年-2023年、2024年-2029年
・世界の抗感染症薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の抗感染症薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「抗ウイルス剤」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

抗感染症薬のグローバル主要企業は、Abbott、 Astellas Pharma、 Bayer、 Bristol-Myers Squibb、 Daiichi Sankyo、 GlaxoSmithKline、 Merck、 Novartis、 Pfizer、 Rocheなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、抗感染症薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の抗感染症薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の抗感染症薬市場：タイプ別市場シェア、2022年
・抗ウイルス剤、抗菌剤、抗真菌剤

世界の抗感染症薬市場：用途別、2018年-2023年、2024年-2029年
世界の抗感染症薬市場：用途別市場シェア、2022年
・病院薬局、オンライン薬局、小売薬局

世界の抗感染症薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の抗感染症薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における抗感染症薬のグローバル売上、2018年-2023年
・主要企業における抗感染症薬のグローバル売上シェア、2022年
・主要企業における抗感染症薬のグローバル販売量、2018年-2023年
・主要企業における抗感染症薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Abbott、 Astellas Pharma、 Bayer、 Bristol-Myers Squibb、 Daiichi Sankyo、 GlaxoSmithKline、 Merck、 Novartis、 Pfizer、 Roche

*************************************************************

・調査・分析レポートの概要
抗感染症薬市場の定義
市場セグメント
世界の抗感染症薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の抗感染症薬市場規模
世界の抗感染症薬市場規模：2022年 VS 2029年
世界の抗感染症薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの抗感染症薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の抗感染症薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：抗ウイルス剤、抗菌剤、抗真菌剤
抗感染症薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院薬局、オンライン薬局、小売薬局
抗感染症薬の用途別グローバル売上・予測

・地域別市場分析
地域別抗感染症薬市場規模 2022年と2029年
地域別抗感染症薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Abbott、 Astellas Pharma、 Bayer、 Bristol-Myers Squibb、 Daiichi Sankyo、 GlaxoSmithKline、 Merck、 Novartis、 Pfizer、 Roche
...

Anti-infectives is a general term used to describe any medicine that is capable of inhibiting the spread of an infectious organism or by killing the infectious organism outright.
This report aims to provide a comprehensive presentation of the global market for Anti-Infective Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Infective Medications. This report contains market size and forecasts of Anti-Infective Medications in global, including the following market information:
Global Anti-Infective Medications Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Anti-Infective Medications Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Anti-Infective Medications companies in 2022 (%)
The global Anti-Infective Medications market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Antivirals Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Anti-Infective Medications include Abbott, Astellas Pharma, Bayer, Bristol-Myers Squibb, Daiichi Sankyo, GlaxoSmithKline, Merck, Novartis and Pfizer, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-Infective Medications manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Infective Medications Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Infective Medications Market Segment Percentages, by Type, 2022 (%)
Antivirals
Antibacterials
Antifungals
Global Anti-Infective Medications Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Infective Medications Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Global Anti-Infective Medications Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Infective Medications Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Infective Medications revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Anti-Infective Medications revenues share in global market, 2022 (%)
Key companies Anti-Infective Medications sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Anti-Infective Medications sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Astellas Pharma
Bayer
Bristol-Myers Squibb
Daiichi Sankyo
GlaxoSmithKline
Merck
Novartis
Pfizer
Roche
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-Infective Medications, market overview.
Chapter 2: Global Anti-Infective Medications market size in revenue and volume.
Chapter 3: Detailed analysis of Anti-Infective Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-Infective Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Anti-Infective Medications capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Anti-Infective Medications Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-Infective Medications Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-Infective Medications Overall Market Size
2.1 Global Anti-Infective Medications Market Size: 2022 VS 2029
2.2 Global Anti-Infective Medications Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Anti-Infective Medications Sales: 2018-2029
3 Company Landscape
3.1 Top Anti-Infective Medications Players in Global Market
3.2 Top Global Anti-Infective Medications Companies Ranked by Revenue
3.3 Global Anti-Infective Medications Revenue by Companies
3.4 Global Anti-Infective Medications Sales by Companies
3.5 Global Anti-Infective Medications Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Anti-Infective Medications Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Anti-Infective Medications Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-Infective Medications Players in Global Market
3.8.1 List of Global Tier 1 Anti-Infective Medications Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-Infective Medications Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Anti-Infective Medications Market Size Markets, 2022 & 2029
4.1.2 Antivirals
4.1.3 Antibacterials
4.1.4 Antifungals
4.2 By Type – Global Anti-Infective Medications Revenue & Forecasts
4.2.1 By Type – Global Anti-Infective Medications Revenue, 2018-2023
4.2.2 By Type – Global Anti-Infective Medications Revenue, 2024-2029
4.2.3 By Type – Global Anti-Infective Medications Revenue Market Share, 2018-2029
4.3 By Type – Global Anti-Infective Medications Sales & Forecasts
4.3.1 By Type – Global Anti-Infective Medications Sales, 2018-2023
4.3.2 By Type – Global Anti-Infective Medications Sales, 2024-2029
4.3.3 By Type – Global Anti-Infective Medications Sales Market Share, 2018-2029
4.4 By Type – Global Anti-Infective Medications Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Anti-Infective Medications Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Online Pharmacies
5.1.4 Retail Pharmacies
5.2 By Application – Global Anti-Infective Medications Revenue & Forecasts
5.2.1 By Application – Global Anti-Infective Medications Revenue, 2018-2023
5.2.2 By Application – Global Anti-Infective Medications Revenue, 2024-2029
5.2.3 By Application – Global Anti-Infective Medications Revenue Market Share, 2018-2029
5.3 By Application – Global Anti-Infective Medications Sales & Forecasts
5.3.1 By Application – Global Anti-Infective Medications Sales, 2018-2023
5.3.2 By Application – Global Anti-Infective Medications Sales, 2024-2029
5.3.3 By Application – Global Anti-Infective Medications Sales Market Share, 2018-2029
5.4 By Application – Global Anti-Infective Medications Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Anti-Infective Medications Market Size, 2022 & 2029
6.2 By Region – Global Anti-Infective Medications Revenue & Forecasts
6.2.1 By Region – Global Anti-Infective Medications Revenue, 2018-2023
6.2.2 By Region – Global Anti-Infective Medications Revenue, 2024-2029
6.2.3 By Region – Global Anti-Infective Medications Revenue Market Share, 2018-2029
6.3 By Region – Global Anti-Infective Medications Sales & Forecasts
6.3.1 By Region – Global Anti-Infective Medications Sales, 2018-2023
6.3.2 By Region – Global Anti-Infective Medications Sales, 2024-2029
6.3.3 By Region – Global Anti-Infective Medications Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Anti-Infective Medications Revenue, 2018-2029
6.4.2 By Country – North America Anti-Infective Medications Sales, 2018-2029
6.4.3 US Anti-Infective Medications Market Size, 2018-2029
6.4.4 Canada Anti-Infective Medications Market Size, 2018-2029
6.4.5 Mexico Anti-Infective Medications Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Anti-Infective Medications Revenue, 2018-2029
6.5.2 By Country – Europe Anti-Infective Medications Sales, 2018-2029
6.5.3 Germany Anti-Infective Medications Market Size, 2018-2029
6.5.4 France Anti-Infective Medications Market Size, 2018-2029
6.5.5 U.K. Anti-Infective Medications Market Size, 2018-2029
6.5.6 Italy Anti-Infective Medications Market Size, 2018-2029
6.5.7 Russia Anti-Infective Medications Market Size, 2018-2029
6.5.8 Nordic Countries Anti-Infective Medications Market Size, 2018-2029
6.5.9 Benelux Anti-Infective Medications Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Anti-Infective Medications Revenue, 2018-2029
6.6.2 By Region – Asia Anti-Infective Medications Sales, 2018-2029
6.6.3 China Anti-Infective Medications Market Size, 2018-2029
6.6.4 Japan Anti-Infective Medications Market Size, 2018-2029
6.6.5 South Korea Anti-Infective Medications Market Size, 2018-2029
6.6.6 Southeast Asia Anti-Infective Medications Market Size, 2018-2029
6.6.7 India Anti-Infective Medications Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Anti-Infective Medications Revenue, 2018-2029
6.7.2 By Country – South America Anti-Infective Medications Sales, 2018-2029
6.7.3 Brazil Anti-Infective Medications Market Size, 2018-2029
6.7.4 Argentina Anti-Infective Medications Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Anti-Infective Medications Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Anti-Infective Medications Sales, 2018-2029
6.8.3 Turkey Anti-Infective Medications Market Size, 2018-2029
6.8.4 Israel Anti-Infective Medications Market Size, 2018-2029
6.8.5 Saudi Arabia Anti-Infective Medications Market Size, 2018-2029
6.8.6 UAE Anti-Infective Medications Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Abbott
7.1.1 Abbott Company Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Anti-Infective Medications Major Product Offerings
7.1.4 Abbott Anti-Infective Medications Sales and Revenue in Global (2018-2023)
7.1.5 Abbott Key News & Latest Developments
7.2 Astellas Pharma
7.2.1 Astellas Pharma Company Summary
7.2.2 Astellas Pharma Business Overview
7.2.3 Astellas Pharma Anti-Infective Medications Major Product Offerings
7.2.4 Astellas Pharma Anti-Infective Medications Sales and Revenue in Global (2018-2023)
7.2.5 Astellas Pharma Key News & Latest Developments
7.3 Bayer
7.3.1 Bayer Company Summary
7.3.2 Bayer Business Overview
7.3.3 Bayer Anti-Infective Medications Major Product Offerings
7.3.4 Bayer Anti-Infective Medications Sales and Revenue in Global (2018-2023)
7.3.5 Bayer Key News & Latest Developments
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Company Summary
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Anti-Infective Medications Major Product Offerings
7.4.4 Bristol-Myers Squibb Anti-Infective Medications Sales and Revenue in Global (2018-2023)
7.4.5 Bristol-Myers Squibb Key News & Latest Developments
7.5 Daiichi Sankyo
7.5.1 Daiichi Sankyo Company Summary
7.5.2 Daiichi Sankyo Business Overview
7.5.3 Daiichi Sankyo Anti-Infective Medications Major Product Offerings
7.5.4 Daiichi Sankyo Anti-Infective Medications Sales and Revenue in Global (2018-2023)
7.5.5 Daiichi Sankyo Key News & Latest Developments
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Company Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Anti-Infective Medications Major Product Offerings
7.6.4 GlaxoSmithKline Anti-Infective Medications Sales and Revenue in Global (2018-2023)
7.6.5 GlaxoSmithKline Key News & Latest Developments
7.7 Merck
7.7.1 Merck Company Summary
7.7.2 Merck Business Overview
7.7.3 Merck Anti-Infective Medications Major Product Offerings
7.7.4 Merck Anti-Infective Medications Sales and Revenue in Global (2018-2023)
7.7.5 Merck Key News & Latest Developments
7.8 Novartis
7.8.1 Novartis Company Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Anti-Infective Medications Major Product Offerings
7.8.4 Novartis Anti-Infective Medications Sales and Revenue in Global (2018-2023)
7.8.5 Novartis Key News & Latest Developments
7.9 Pfizer
7.9.1 Pfizer Company Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Anti-Infective Medications Major Product Offerings
7.9.4 Pfizer Anti-Infective Medications Sales and Revenue in Global (2018-2023)
7.9.5 Pfizer Key News & Latest Developments
7.10 Roche
7.10.1 Roche Company Summary
7.10.2 Roche Business Overview
7.10.3 Roche Anti-Infective Medications Major Product Offerings
7.10.4 Roche Anti-Infective Medications Sales and Revenue in Global (2018-2023)
7.10.5 Roche Key News & Latest Developments
8 Global Anti-Infective Medications Production Capacity, Analysis
8.1 Global Anti-Infective Medications Production Capacity, 2018-2029
8.2 Anti-Infective Medications Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-Infective Medications Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-Infective Medications Supply Chain Analysis
10.1 Anti-Infective Medications Industry Value Chain
10.2 Anti-Infective Medications Upstream Market
10.3 Anti-Infective Medications Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-Infective Medications Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Anti-Infective Medications in Global Market
Table 2. Top Anti-Infective Medications Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Anti-Infective Medications Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Anti-Infective Medications Revenue Share by Companies, 2018-2023
Table 5. Global Anti-Infective Medications Sales by Companies, (K Units), 2018-2023
Table 6. Global Anti-Infective Medications Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Anti-Infective Medications Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Anti-Infective Medications Product Type
Table 9. List of Global Tier 1 Anti-Infective Medications Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-Infective Medications Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Anti-Infective Medications Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Anti-Infective Medications Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Anti-Infective Medications Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Anti-Infective Medications Sales (K Units), 2018-2023
Table 15. By Type - Global Anti-Infective Medications Sales (K Units), 2024-2029
Table 16. By Application – Global Anti-Infective Medications Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Anti-Infective Medications Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Anti-Infective Medications Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Anti-Infective Medications Sales (K Units), 2018-2023
Table 20. By Application - Global Anti-Infective Medications Sales (K Units), 2024-2029
Table 21. By Region – Global Anti-Infective Medications Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Anti-Infective Medications Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Anti-Infective Medications Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Anti-Infective Medications Sales (K Units), 2018-2023
Table 25. By Region - Global Anti-Infective Medications Sales (K Units), 2024-2029
Table 26. By Country - North America Anti-Infective Medications Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Anti-Infective Medications Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Anti-Infective Medications Sales, (K Units), 2018-2023
Table 29. By Country - North America Anti-Infective Medications Sales, (K Units), 2024-2029
Table 30. By Country - Europe Anti-Infective Medications Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Anti-Infective Medications Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Anti-Infective Medications Sales, (K Units), 2018-2023
Table 33. By Country - Europe Anti-Infective Medications Sales, (K Units), 2024-2029
Table 34. By Region - Asia Anti-Infective Medications Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Anti-Infective Medications Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Anti-Infective Medications Sales, (K Units), 2018-2023
Table 37. By Region - Asia Anti-Infective Medications Sales, (K Units), 2024-2029
Table 38. By Country - South America Anti-Infective Medications Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Anti-Infective Medications Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Anti-Infective Medications Sales, (K Units), 2018-2023
Table 41. By Country - South America Anti-Infective Medications Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Anti-Infective Medications Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Anti-Infective Medications Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Anti-Infective Medications Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Anti-Infective Medications Sales, (K Units), 2024-2029
Table 46. Abbott Company Summary
Table 47. Abbott Anti-Infective Medications Product Offerings
Table 48. Abbott Anti-Infective Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Abbott Key News & Latest Developments
Table 50. Astellas Pharma Company Summary
Table 51. Astellas Pharma Anti-Infective Medications Product Offerings
Table 52. Astellas Pharma Anti-Infective Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Astellas Pharma Key News & Latest Developments
Table 54. Bayer Company Summary
Table 55. Bayer Anti-Infective Medications Product Offerings
Table 56. Bayer Anti-Infective Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Bayer Key News & Latest Developments
Table 58. Bristol-Myers Squibb Company Summary
Table 59. Bristol-Myers Squibb Anti-Infective Medications Product Offerings
Table 60. Bristol-Myers Squibb Anti-Infective Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Bristol-Myers Squibb Key News & Latest Developments
Table 62. Daiichi Sankyo Company Summary
Table 63. Daiichi Sankyo Anti-Infective Medications Product Offerings
Table 64. Daiichi Sankyo Anti-Infective Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Daiichi Sankyo Key News & Latest Developments
Table 66. GlaxoSmithKline Company Summary
Table 67. GlaxoSmithKline Anti-Infective Medications Product Offerings
Table 68. GlaxoSmithKline Anti-Infective Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. GlaxoSmithKline Key News & Latest Developments
Table 70. Merck Company Summary
Table 71. Merck Anti-Infective Medications Product Offerings
Table 72. Merck Anti-Infective Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Merck Key News & Latest Developments
Table 74. Novartis Company Summary
Table 75. Novartis Anti-Infective Medications Product Offerings
Table 76. Novartis Anti-Infective Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Novartis Key News & Latest Developments
Table 78. Pfizer Company Summary
Table 79. Pfizer Anti-Infective Medications Product Offerings
Table 80. Pfizer Anti-Infective Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Pfizer Key News & Latest Developments
Table 82. Roche Company Summary
Table 83. Roche Anti-Infective Medications Product Offerings
Table 84. Roche Anti-Infective Medications Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Roche Key News & Latest Developments
Table 86. Anti-Infective Medications Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 87. Global Anti-Infective Medications Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Anti-Infective Medications Production by Region, 2018-2023 (K Units)
Table 89. Global Anti-Infective Medications Production by Region, 2024-2029 (K Units)
Table 90. Anti-Infective Medications Market Opportunities & Trends in Global Market
Table 91. Anti-Infective Medications Market Drivers in Global Market
Table 92. Anti-Infective Medications Market Restraints in Global Market
Table 93. Anti-Infective Medications Raw Materials
Table 94. Anti-Infective Medications Raw Materials Suppliers in Global Market
Table 95. Typical Anti-Infective Medications Downstream
Table 96. Anti-Infective Medications Downstream Clients in Global Market
Table 97. Anti-Infective Medications Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anti-Infective Medications Segment by Type in 2022
Figure 2. Anti-Infective Medications Segment by Application in 2022
Figure 3. Global Anti-Infective Medications Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anti-Infective Medications Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Anti-Infective Medications Revenue, 2018-2029 (US$, Mn)
Figure 7. Anti-Infective Medications Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Anti-Infective Medications Revenue in 2022
Figure 9. By Type - Global Anti-Infective Medications Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Anti-Infective Medications Revenue Market Share, 2018-2029
Figure 11. By Type - Global Anti-Infective Medications Sales Market Share, 2018-2029
Figure 12. By Type - Global Anti-Infective Medications Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Anti-Infective Medications Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Anti-Infective Medications Revenue Market Share, 2018-2029
Figure 15. By Application - Global Anti-Infective Medications Sales Market Share, 2018-2029
Figure 16. By Application - Global Anti-Infective Medications Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Anti-Infective Medications Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Anti-Infective Medications Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Anti-Infective Medications Revenue Market Share, 2018-2029
Figure 20. By Region - Global Anti-Infective Medications Sales Market Share, 2018-2029
Figure 21. By Country - North America Anti-Infective Medications Revenue Market Share, 2018-2029
Figure 22. By Country - North America Anti-Infective Medications Sales Market Share, 2018-2029
Figure 23. US Anti-Infective Medications Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Anti-Infective Medications Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Anti-Infective Medications Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Anti-Infective Medications Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Anti-Infective Medications Sales Market Share, 2018-2029
Figure 28. Germany Anti-Infective Medications Revenue, (US$, Mn), 2018-2029
Figure 29. France Anti-Infective Medications Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Anti-Infective Medications Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Anti-Infective Medications Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Anti-Infective Medications Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Anti-Infective Medications Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Anti-Infective Medications Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Anti-Infective Medications Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Anti-Infective Medications Sales Market Share, 2018-2029
Figure 37. China Anti-Infective Medications Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Anti-Infective Medications Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Anti-Infective Medications Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Anti-Infective Medications Revenue, (US$, Mn), 2018-2029
Figure 41. India Anti-Infective Medications Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Anti-Infective Medications Revenue Market Share, 2018-2029
Figure 43. By Country - South America Anti-Infective Medications Sales Market Share, 2018-2029
Figure 44. Brazil Anti-Infective Medications Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Anti-Infective Medications Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Anti-Infective Medications Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Anti-Infective Medications Sales Market Share, 2018-2029
Figure 48. Turkey Anti-Infective Medications Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Anti-Infective Medications Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Anti-Infective Medications Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Anti-Infective Medications Revenue, (US$, Mn), 2018-2029
Figure 52. Global Anti-Infective Medications Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Anti-Infective Medications by Region, 2022 VS 2029
Figure 54. Anti-Infective Medications Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 抗感染症薬の世界市場見通し2023年-2029年(Anti-Infective Medications Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

抗感染症薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp